Clinical Trials Browser

Phase 2 × ibritumomab tiuxetan × Plasma cell × Clear all

NCT01207765 2017-03-20

Zevalin for Patients With Incomplete Response to Chemo Prior to Autologous Stem Cell Transplant for Multiple Myeloma

Phase 2 Terminated

8 enrolled 8 charts

Multiple Myeloma